| |
 |
|
Class Information
Number: 536/6.4
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > O- or s- glycosides > Daunomycin or derivative
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7560483 |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
Jul. 14, 2009 |
| 7534766 |
Glucuronide metabolites and epimers thereof of tigecycline |
May. 19, 2009 |
| 7485707 |
Thermally stable crystalline epirubicin hydrochloride and method of making the same |
Feb. 3, 2009 |
| 7445764 |
Carrier-drug conjugate |
Nov. 4, 2008 |
| 7402556 |
Prodrugs activated by plasmin and their use in cancer chemotherapy |
Jul. 22, 2008 |
| 7388083 |
Epimerization of 4'-C bond and modification of 14-CH.sub.3-(CO)-fragment in anthracyclin antibiotics |
Jun. 17, 2008 |
| 7345023 |
Treatment of hyperproliferative conditions of body surfaces |
Mar. 18, 2008 |
| 7244829 |
Compositions and processes for preparing 13-deoxy-anthracyclines |
Jul. 17, 2007 |
| 7153946 |
Molecular conjugates for use in treatment of cancer |
Dec. 26, 2006 |
| 7115576 |
Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
Oct. 3, 2006 |
| 7109177 |
Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics |
Sep. 19, 2006 |
| 7091188 |
Stabilization of amrubicin hydrochloride |
Aug. 15, 2006 |
| 7053191 |
Method of preparing 4-R-substituted 4-demethoxydaunorubicin |
May. 30, 2006 |
| 7005421 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Feb. 28, 2006 |
| 7001991 |
Targeted delivery of bioaffecting compounds for the treatment of cancer |
Feb. 21, 2006 |
| 6927211 |
Method for reducing toxicity of combined chemotherapies |
Aug. 9, 2005 |
| 6921841 |
Process for the synthesis of optically active anthracyclines |
Jul. 26, 2005 |
| 6914046 |
NF-.kappa.B activation inhibitors, and their pharmaceutical uses |
Jul. 5, 2005 |
| 6906040 |
Method for reducing toxicity of combined chemotherapies |
Jun. 14, 2005 |
| 6844318 |
Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
Jan. 18, 2005 |
| 6825166 |
Molecular conjugates for use in treatment of cancer |
Nov. 30, 2004 |
| 6720306 |
Tetrapartate prodrugs |
Apr. 13, 2004 |
| 6716821 |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
Apr. 6, 2004 |
| 6709679 |
Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
Mar. 23, 2004 |
| 6680300 |
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents |
Jan. 20, 2004 |
| 6677309 |
Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods |
Jan. 13, 2004 |
| 6673907 |
Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics |
Jan. 6, 2004 |
| 6670348 |
Methods and compositions for destruction of selected proteins |
Dec. 30, 2003 |
| 6653455 |
Crystallization of doxorubicin hydrochloride |
Nov. 25, 2003 |
| 6653289 |
L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them |
Nov. 25, 2003 |
| 6630579 |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
Oct. 7, 2003 |
| 6624142 |
Trimethyl lock based tetrapartate prodrugs |
Sep. 23, 2003 |
| 6596697 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Jul. 22, 2003 |
| 6500936 |
Pluraflavins and derivatives thereof, process for their preparation and use thereof |
Dec. 31, 2002 |
| 6437105 |
Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents |
Aug. 20, 2002 |
| 6433150 |
Anthracycline analogues bearing latent alkylating substituents |
Aug. 13, 2002 |
| 6399583 |
Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof |
Jun. 4, 2002 |
| 6391305 |
Conjugates useful in the treatment of prostate cancer |
May. 21, 2002 |
| 6388058 |
Method of purifying daunomycin |
May. 14, 2002 |
| 6376469 |
Crystalline amrubicin hydrochloride |
Apr. 23, 2002 |
| 6355784 |
Methods and compositions for the manufacture of halogenated anthracyclines with increased antitumor activity, other anthracyclines, halogenated sugars, and glycosyl donors |
Mar. 12, 2002 |
| 6303569 |
Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
Oct. 16, 2001 |
| 6284737 |
Methods of treatment with anthracycline derivatives |
Sep. 4, 2001 |
| 6284738 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Sep. 4, 2001 |
| 6281342 |
Pradimicin compounds |
Aug. 28, 2001 |
| 6268488 |
Prodrug activation using catalytic antibodies |
Jul. 31, 2001 |
| 6258786 |
13-dihydro-3' aziridino anthracyclines |
Jul. 10, 2001 |
| 6218519 |
Compounds and methods for the selective treatment of cancer and bacterial infections |
Apr. 17, 2001 |
| 6187758 |
Anthracycline glycosides |
Feb. 13, 2001 |
| 6184365 |
Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2 fluoro-.alpha.-L-talopyranosyl group |
Feb. 6, 2001 |
|
|
|
